Phase II/III study of M606102 in the treatment of axillary hyperhidrosis

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080224742

Enrollment

450

Registered

2019-06-24

Start date

2019-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

axillary hyperhidrosis

Interventions

investigational material(s) Generic name etc : Glycopyrronium tosylate monohydrate INN of investigational material : - Therapeutic category code : --- Other Dosage and Administration for Investigation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: axillary hyperhidrosis patients

Exclusion criteria

Exclusion criteria: Patients who have the disease considered inappropriate for participation in clinical trial

Design outcomes

Primary

Measure	Time frame
efficacy confirmatory gravimetrically-measured sweat production and QOL assessments	—

Secondary

Measure	Time frame
efficacy confirmatory gravimetrically-measured sweat production and QOL assessments	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026